Open access
Aug 2026
Tissue-specific metabolomics in experimental HFpEF reveals hepatic remodelling modulated by SGLT2 inhibition
It is suggested that extra-cardiac metabolic pathways, particularly liver-centered mechanisms, may contribute to the therapeutic benefits of SGLT2 inhibitors in HFpEF and provide new insights into inter-organ metabolic regulation.
M. Kiyar, Ruth R Magaye, Shanae Bailey et al.
· Cellular and Molecular Life... · 0 citations